Clinical trialUNITERAREToday
New Recruiting Trial: Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Researchers are testing a new device called synchronized diaphragmatic stimulation to help people with symptomatic heart failure. The diaphragm is the muscle that helps you breathe, and this device stimulates it in a coordinated way to potentially improve how well the heart works. The trial is now accepting patients and is expected to start in April 2026.
WHY IT MATTERSThis trial offers a potential new treatment option for heart failure patients who may not respond well to current medications or devices, with enrollment now open at participating sites.